JAMDA
October 6, 2016
Showing 101 - 110 of 137 results
JAMDA
September 23, 2016
Refining Mild-to-Moderate Alzheimer Disease Screening: A Tool for Clinicians
Recent evidence suggests that a substantial minority of people clinically diagnosed with probable Alzheimer disease (AD) in fact do not fulfill the neuropathological criteria for the disease. A clinical hallmark of these phenocopies of AD is that these individuals tend to remain cognitively stable for exte...
JAMDA
September 16, 2016
The Diagnosis of Delirium Superimposed on Dementia: An Emerging Challenge
Delirium occurring in patients with dementia is referred to as delirium superimposed on dementia (DSD). People who are older with dementia and who are institutionalized are at increased risk of developing delirium when hospitalized. In addition, their prior cognitive impairment makes detecting their deliri...
JAMDA
August 26, 2016
Risk Factors of Caregiver Burden Evolution, for Patients With Subjective Cognitive Decline or Neurocognitive Disorders: A Longitudinal Analysis
The identification of factors used to predict caregiver burden may help preventive care. This study aimed to assess the relationship between evolution of patients with subjective cognitive decline (SCD) or progressive neurocognitive disorder (NCD) and evolution of caregiver burden.
JAMDA
August 5, 2016
Spontaneous Reversion of Mild Cognitive Impairment to Normal Cognition: A Systematic Review of Literature and Meta-Analysis
The issue of subjects with mild cognitive impairment (MCI) reverting to normal cognition (NC) has to date been taken in limited consideration, and no conclusive data are available on the rate of reversion. We aimed at systematically reviewing available longitudinal studies on MCI and meta-analyzing data wi...
JAMDA
July 25, 2016
Active Vaccines for Alzheimer Disease Treatment
Vaccination against peptides specific to Alzheimer disease may generate an immune response that could help inhibit disease and symptom progression.
JAMDA
June 24, 2016
Combination Therapy Showed Limited Superiority Over Monotherapy for Alzheimer Disease: A Meta-analysis of 14 Randomized Trials
Acetylcholinesterase inhibitor (AChEI) and memantine are recognized drug treatments with limited clinical efficacy. Combination therapy for patients with Alzheimer disease (AD) was suggested, but the additional benefit of combination therapy is still controversial.
JAMDA
June 23, 2016
Prevalence and Medication Management of Dementia by a Medical Practice Providing Onsite Care in Assisted Living
Assisted living (AL) is an important provider of long-term residential care to people with dementia, but little research has used clinician's records—arguably the most reliable and valid source of medically related information. This article uses clinician records to examine the prevalence of dementia,...
JAMDA
June 17, 2016
Frailty as a Predictor of Alzheimer Disease, Vascular Dementia, and All Dementia Among Community-Dwelling Older People: A Systematic Review and Meta-Analysis
To perform a systematic search of the literature for currently available evidence on frailty as a predictor of dementia and to conduct a meta-analysis to synthesize the pooled risk estimates among community-dwelling older people.
JAMDA
May 26, 2016
The Group Reminiscence Approach Can Increase Self-Awareness of Memory Deficits and Evoke a Life Review in People With Mild Cognitive Impairment: The Kurihara Project Data
The group reminiscence approach (GRA) and reality orientation (RO) are common psychosocial interventions for patients with dementia. As a qualitative evaluation of the reminiscence approach in patients with dementia, the Patient Report Outcome (PRO) is useful. The purpose of this study was to investigate t...
Tools, knowledge, and recognition to improve vaccination rates and protect residents and staff.
